clinical study to evaluate the efficacy and safety of DENPAP of liquid syrup in the treatment of Dengue fever

Not Applicable

Completed

• Conditions: Health Condition 1: A91- Dengue hemorrhagic fever

• Registration Number: CTRI/2014/06/004660
• Lead Sponsor: GOAN Pharma P Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2014-06-27
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 15

Inclusion Criteria

1.Males and females of age group 18-60 years

2.Subjects with low platelet count(>=70,000) and IgG or IgM or both antibodies positive cases only

3.Subjects who are willing to give written informed consent along with audio, video recording

4.Patient is willing and able to comply with all trial requirements

Exclusion Criteria

1.Patients with adequate platelet count and IgG and IgM antibodies negative

2.Subjects had bleeding manifestations or mixed infections (tested positive for malaria, leptospirosis along with dengue) or a recent ( <120 days) transfusion of plate-lets & whole blood

3.Have a history of Angina, stroke, thyroid diseases

4.Present history of mental diseases

5.Previous participation in a clinical trial within 6 months.

6.Pregnant or lactating woman

Study & Design

• Study Type: Interventional
• Study Design: Not specified